Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients;Detección del ARNm de tiroglobulina y del receptor de TSH mediante RT-PCR, en la sangre de pacientes en seguimiento por carcinoma diferenciado de tiroides

Revista Espanola de Medicina Nuclear

Volumn 29, Issue 3, 2010, Pages 109-113

  Torosian, L ^a   Manrique, G ^a   Alvarez, B ^a   Lago, G ^a   Roca, R ^a   Belzarena, C ^a  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

Antithyroglobulin antibodies; Differentiated thyroid cancer; Thyroglobulin mRNA; TSH R mRNA

Indexed keywords

LEVOTHYROXINE; MESSENGER RNA; THYROGLOBULIN; THYROTROPIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; MALE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; COMBINED MODALITY THERAPY; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; NEOPLASTIC CELLS, CIRCULATING; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RECEPTORS, THYROTROPIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 77952551351     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/j.remn.2009.12.010     Document Type: Article

References (28)

1. Belzarena C., Lago G., Lang R., Ortega V., Rodriguez A., Caputi S., et al. Propuesta 2000 para el tratamiento y seguimiento del carcinoma diferenciado de Tiroides. Endocrinol Nutr 2001, 48:70-76.
2. Solomon B., Wartofsky L., Burman K. Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 1996, 81:333-339.
3. Spencer C.A., Takeuchi M., Kazarosyan M., Wang C.C., Guttler R.B., Singer P.A., et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998, 83:1121-1127.
4. Biscolla R.P., Cerutti J.M., Maciel R. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood. J Clin Endocrinol Metab 2000, 85:3623-3627.
5. Ringel M.D., Ladenson P.W., Levine M.A. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 1998, 83:4435-4442.
6. Ringel M.D., Balducci-Silano P.L., Anderson J.S., Spencer C.A., Silverman J., Sparling Y.H., et al. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. J Clin Endocrinol Metab 1999, 84:4037-4042.
7. Fugazzola L., Mihalich A., Persani L., Cerutti N., Reina M., Bonomi M., et al. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission. J Clin Endocrinol Metab 2002, 87:3201-3208.
8. Bojunga J., Roddiger S., Stanisch M., Kusterer K., Kurek R., Renneberg H., et al. Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR. Br J Cancer 2000, 82:1650-1655.
9. Takano T., Miyauchi A., Yoshida H., Hasegawa Y., Kuma K., Amino N. Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy. Br J Cancer 2001, 85:102-106.
10. Bellantone R., Pio Lombardi C., Bossola M., Ferrante A., Princi P., Boscherini M., et al. Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type. Cancer 2001, 92:2273-2279.
11. Eszlinger M., Neumann S., Lothar O., Paschke R. Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow up of patients with differentiated thyroid cancer. Eur J Endocrinol 2002, 147:575-582.
12. Chinnappa P., Taguba L., Arciaga R., Faiman C., Siperstein A., Mehta A.E., et al. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer. J Clin Endocrinol Metab 2004, 89:3705-3709.
13. Elisei R., Vivaldi A., Agate L., Molinaro E., Nencetti C., Grasso L., et al. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. J Clin Endocrinol Metab 2004, 89:33-39.
14. Savagner F., Rodien P., Reynier P., Rohmer V., Bigorgne J.C., Malthiery Y. Analysis of Tg transcripts by real-time RT-PCR in the blood of thyroid cancer patients. J Clin Endocrinol Metab 2002, 87:635-639.
15. Bugalho M.J., Domingues R.S., Pinto A.C., Garrao A., Catarino A.L., Ferreira T., et al. Detection of thyroglobulin mRNA transcripts in peripheral blood of individuals with and without thyroid glands: evidence for thyroglobulin expression by blood cells. Eur J Endocrinol 2001, 145:409-413.
16. Francis T., Burch H.B., Cai W.Y., Lukes Y., Peele M., Carr F.E., et al. Lymphocytes express thyrotropin receptor-specific mRNA as detected by the PCR technique. Thyroid 1991, 1:223-228.
17. Leygue E., Dotzlaw H., Watson P.H., Murphy L. Altered estrogen receptor α and Β messenger RNA expression during human breast tumorigenesis. Cancer Res 1998, 58:3197-3201.
18. Sasso F.C., Carbonara O., Persico E., D'Ambrosio R., Coppola L., Nasti R., et al. Increased vascular endothelial growth factor RNA expression in the heart of streptozotocin-induced diabetic rats. Metabolism 2003, 52:675-678.
19. Guyon T., Levasseur P., Truffault F., Cottin C., Gaud C., Berrih-Aknin S. Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. J Clin Invest 1994, 94:16-24.
20. Maltheiry Y., Lissitzky S. Primary structure of a human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur J Biochem 1987, 165:491-498.
21. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
22. Sarker G., Sommer S.S. Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science 1989, 244:331-334.
23. Gupta M.K., Taguba L., Areiaga R., Siperstein A., Faiman C., Mehta A., et al. Detection of circulating thyroid cancer cells by reverse transcription-PCR for thyroid stimulating hormone receptor and thyroglobulin: the importance of primer selection. Clin Chem 2002, 48:1862-1865.
24. Wingo S.T., Ringel M.D., Anderson J.S., Patel A.D., Lukes Y.D., Djuh Y.Y., et al. Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects. Clin Chem 1999, 45:785-789.
25. Deziot A., Delfino C., Dutour-Meyer A., Fina F., Ouafik L. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer. Thyroid 2003, 13:867-872.
26. Wagner K., Arciaga R., Siperstein A., Milas M., Warshawsky I., Reddy S.K., et al. Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnostic synergy for detecting thyroid cancer. J Clin Endocrinol Metab 2005, 90:1921-1924.
27. Chia S.Y., Milas M., Reddy S.K., Siperstein A., Skugor M., Brainard J., et al. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer. J Clin Endocrinol Metab 2007, 92:468-475.
28. Milas M., Barbosa G.F., Mitchell J., Berber E., Siperstein A., Gupta M. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer. Ann Surg Oncol 2009, 16:473-480.